Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
China · Delayed Price · Currency is CNY 37.97
-0.79 (-2.04%)
Nov 13, 2026, 3:00 PM CST
SHA:688580 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 455.87 | 456.47 | 395.34 | 455.44 | 319.67 | 428.73 |
Other Revenue | 6.26 | 6.26 | 4.72 | 6.78 | 1.95 | 1.31 |
| 462.13 | 462.73 | 400.06 | 462.22 | 321.62 | 430.04 | |
Revenue Growth | 6.52% | 15.66% | -13.45% | 43.72% | -25.21% | 13.66% |
Cost of Revenue | 160.25 | 156.89 | 138.26 | 149.16 | 88.52 | 108.45 |
Gross Profit | 301.88 | 305.84 | 261.8 | 313.06 | 233.1 | 321.59 |
Selling, General & Admin | 137.24 | 139.16 | 138.92 | 152.48 | 129.71 | 116.08 |
Research & Development | 46.16 | 45.12 | 50.61 | 57.65 | 43.73 | 63.52 |
Other Operating Expenses | -9.7 | -11.26 | -11.64 | -14.08 | -7.67 | -6.97 |
Operating Expenses | 174.56 | 173.86 | 179.33 | 198.31 | 166.29 | 173.52 |
Operating Income | 127.32 | 131.98 | 82.48 | 114.75 | 66.82 | 148.07 |
Interest Expense | -0.27 | -1.31 | -1.31 | -1.32 | -0.33 | -0.18 |
Interest & Investment Income | 15.6 | 16.75 | 21.11 | 29.9 | 35.29 | 37.35 |
Other Non Operating Income (Expenses) | -0.49 | -0.05 | 0.14 | 0.06 | -0.2 | -0.04 |
EBT Excluding Unusual Items | 142.17 | 147.37 | 102.42 | 143.39 | 101.57 | 185.2 |
Gain (Loss) on Sale of Investments | 4.84 | 4.84 | 2.42 | -0.96 | - | - |
Gain (Loss) on Sale of Assets | 33.02 | -0 | 0 | -0 | -0.01 | -0.01 |
Asset Writedown | 0.1 | - | -0.01 | -0.01 | - | - |
Other Unusual Items | 2.02 | 2.23 | 8.45 | 7.6 | 4.29 | 12.19 |
Pretax Income | 182.15 | 154.43 | 113.28 | 150.01 | 105.84 | 197.38 |
Income Tax Expense | 22.26 | 16.36 | 11.31 | 13.75 | 12.01 | 19.84 |
Earnings From Continuing Operations | 159.89 | 138.07 | 101.97 | 136.26 | 93.83 | 177.54 |
Minority Interest in Earnings | - | - | - | - | - | 0.28 |
Net Income | 159.89 | 138.07 | 101.97 | 136.26 | 93.83 | 177.81 |
Net Income to Common | 159.89 | 138.07 | 101.97 | 136.26 | 93.83 | 177.81 |
Net Income Growth | 26.95% | 35.41% | -25.16% | 45.23% | -47.23% | 23.77% |
Shares Outstanding (Basic) | 96 | 96 | 95 | 96 | 96 | 96 |
Shares Outstanding (Diluted) | 96 | 96 | 95 | 96 | 96 | 96 |
Shares Change | 0.42% | 0.61% | -0.43% | 0.05% | -0.31% | 17.41% |
EPS (Basic) | 1.67 | 1.44 | 1.07 | 1.43 | 0.98 | 1.86 |
EPS (Diluted) | 1.67 | 1.44 | 1.07 | 1.42 | 0.98 | 1.85 |
EPS Growth | 26.42% | 34.58% | -24.84% | 45.16% | -47.07% | 5.42% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 19.86 | 58.63 | 5.21 | 0.72 | -9.45 | 70.02 |
Free Cash Flow Per Share | 0.21 | 0.61 | 0.06 | 0.01 | -0.10 | 0.73 |
Dividend Per Share | 0.108 | 0.108 | 0.800 | 1.076 | 0.491 | 0.930 |
Dividend Growth | -86.48% | -86.48% | -25.62% | 119.02% | -47.19% | 23.87% |
Gross Margin | 65.32% | 66.09% | 65.44% | 67.73% | 72.48% | 74.78% |
Operating Margin | 27.55% | 28.52% | 20.62% | 24.82% | 20.77% | 34.43% |
Profit Margin | 34.60% | 29.84% | 25.49% | 29.48% | 29.17% | 41.35% |
Free Cash Flow Margin | 4.30% | 12.67% | 1.30% | 0.15% | -2.94% | 16.28% |
EBITDA | 157.01 | 157.83 | 103.2 | 133.69 | 82.77 | 157.96 |
EBITDA Margin | 33.98% | 34.11% | 25.80% | 28.92% | 25.74% | 36.73% |
D&A For EBITDA | 29.69 | 25.85 | 20.72 | 18.95 | 15.95 | 9.89 |
EBIT | 127.32 | 131.98 | 82.48 | 114.75 | 66.82 | 148.07 |
EBIT Margin | 27.55% | 28.52% | 20.62% | 24.82% | 20.77% | 34.43% |
Effective Tax Rate | 12.22% | 10.59% | 9.98% | 9.17% | 11.35% | 10.05% |
Revenue as Reported | 462.13 | 462.73 | 400.06 | 462.22 | 321.62 | 430.04 |